Molina-Ortiz, D.; Torres-Zárate, C.; Cárdenas-Cardós, R.; Hernández-Arrazola, D.; Aguilar-Ortiz, M.R.; Palacios-Acosta, J.; Shalkow-Klincovstein, J.; Dorado-González, V.; Santes-Palacios, R.; Hernández-Urzúa, E.;
et al. Aberrant Expression of CYP2W1 in Pediatric Soft Tissue Sarcomas: Clinical Significance and Potential as a Therapeutic Target. Curr. Oncol. 2025, 32, 131.
https://doi.org/10.3390/curroncol32030131
AMA Style
Molina-Ortiz D, Torres-Zárate C, Cárdenas-Cardós R, Hernández-Arrazola D, Aguilar-Ortiz MR, Palacios-Acosta J, Shalkow-Klincovstein J, Dorado-González V, Santes-Palacios R, Hernández-Urzúa E,
et al. Aberrant Expression of CYP2W1 in Pediatric Soft Tissue Sarcomas: Clinical Significance and Potential as a Therapeutic Target. Current Oncology. 2025; 32(3):131.
https://doi.org/10.3390/curroncol32030131
Chicago/Turabian Style
Molina-Ortiz, Dora, Carmen Torres-Zárate, RocÃo Cárdenas-Cardós, Daniel Hernández-Arrazola, Marco R. Aguilar-Ortiz, José Palacios-Acosta, Jaime Shalkow-Klincovstein, VÃctor Dorado-González, Rebeca Santes-Palacios, Elizabeth Hernández-Urzúa,
and et al. 2025. "Aberrant Expression of CYP2W1 in Pediatric Soft Tissue Sarcomas: Clinical Significance and Potential as a Therapeutic Target" Current Oncology 32, no. 3: 131.
https://doi.org/10.3390/curroncol32030131
APA Style
Molina-Ortiz, D., Torres-Zárate, C., Cárdenas-Cardós, R., Hernández-Arrazola, D., Aguilar-Ortiz, M. R., Palacios-Acosta, J., Shalkow-Klincovstein, J., Dorado-González, V., Santes-Palacios, R., Hernández-Urzúa, E., & Vences-MejÃa, A.
(2025). Aberrant Expression of CYP2W1 in Pediatric Soft Tissue Sarcomas: Clinical Significance and Potential as a Therapeutic Target. Current Oncology, 32(3), 131.
https://doi.org/10.3390/curroncol32030131
